First HCT Following CAR T-Cell Therapy Reduces Risk for ALL Relapse

Receiving a stem cell transplant for the first time following CD19 CAR T-cell therapy induced a reduction in the risk for acute lymphoblastic leukemia (ALL) recurrence, according to a retrospective analysis of the phase I/II PLAT-02 study. 1 However, those … (본문 전체 12/2/2018 12:23 PM)